Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial-Reference-Cited by-同舟云学术

Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial

Published:2023-02-06 Issue:5 Volume:52 Page:481-492
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Uhrenholt L¹²³^ORCID,Christensen R³⁴^ORCID,Dreyer L¹²^ORCID,Hauge E-M⁵⁶^ORCID,Schlemmer A¹⁶⁷,Loft AG⁵⁶^ORCID,Rasch MNB⁵,Horn HC⁸^ORCID,Gade KH¹⁸,Østgård RD⁹^ORCID,Taylor PC¹⁰^ORCID,Duch K¹¹¹^ORCID,Kristensen S¹²⁵⁶^ORCID

Affiliation:

1. Center of Rheumatic Research Aalborg (CERRA), Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark

2. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

3. Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark

4. Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark

5. Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark

6. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

7. Department of Rheumatology, Randers Regional Hospital, Randers, Denmark

8. Department of Rheumatology, Odense University Hospital, Odense, Denmark

9. Department of Rheumatology, Silkeborg Regional Hospital, Silkeborg, Denmark

10. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK

11. Unit of Epidemiology and Biostatistics, Aalborg University Hospital, Aalborg, Denmark

Funder

the Danish Regions Medicine grants

the Danish Rheumatism Association

Manufacturer Vilhelm Pedersen and Wife’s grant after a recommendation from the Novo Nordisk Foundation

Aase and Ejnar Danielsen grant

the Health Science Research Fund of the North Denmark Region

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2023.2164979

Reference43 articles.

1. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis

2. Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis

3. Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

4. Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial;Rheumatology International;2024-07-24

2. Dose Tapering and Discontinuation of Biologic DMARDs in Axial Spondyloarthritis: A Narrative Review (2023 SPARTAN Annual Meeting Proceedings);Current Rheumatology Reports;2024-02-09

3. To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question;Best Practice & Research Clinical Rheumatology;2023-09

4. Digitale Erfassung der Krankheitsaktivität – Einblicke in ein Versorgungsforschungsprojekt.;Aktuelle Rheumatologie;2023-08

5. Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial;British Journal of Clinical Pharmacology;2023-06-27